-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

BRIEF-Immunome Completes Dosing First Cohort Of Patients In Phase 1b Study Of IMM-BCP-01

Reuters · 01/06/2023 08:25
BRIEF-Immunome Completes Dosing First Cohort Of Patients In Phase 1b Study Of IMM-BCP-01

- Immunome Inc IMNM.O:

  • IMMUNOME - COMPLETED DOSING OF FIRST COHORT OF PATIENTS IN PHASE 1B STUDY OF IMM-BCP-01 WITH NO SIGNIFICANT TREATMENT-RELATED ADVERSE EVENTS

  • IMMUNOME INC - HAS DECIDED TO SEEK A PARTNER IN ORDER TO CONTINUE TRIAL AND FOR ANY FURTHER DEVELOPMENT ACTIVITIES

Further company coverage: IMNM.O


((Reuters.Briefs@thomsonreuters.com;))